Heron Therapeuti Stock Annual Yield

HRTX Stock

USD 2.32 0.09 3.73%

Heron Therapeuti fundamentals help investors to digest information that contributes to Heron Therapeuti's financial success or failures. It also enables traders to predict the movement of Heron Stock. The fundamental analysis module provides a way to measure Heron Therapeuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Heron Therapeuti stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Heron Therapeuti Company Annual Yield Analysis

Heron Therapeuti's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Heron Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Heron Therapeuti is extremely important. It helps to project a fair market value of Heron Stock properly, considering its historical fundamentals such as Annual Yield. Since Heron Therapeuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heron Therapeuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heron Therapeuti's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.74	0.09	-0.63	0.69	0.49	1.0	0.39	0.36	-0.04	0.87	0.6	0.7	0.8	0.76	0.32	0.82	0.82	0.83	0.25
Total Stockholder Equity	0.74		-0.55	0.05	0.1	-0.23	0.78	0.32	0.14	-0.22	0.86	-0.08	0.17	0.99	0.13	0.08	0.32	0.91	0.91	-0.4
Net Debt	0.09	-0.55		-0.74	0.62	0.84	0.03	-0.32	0.11	0.31	-0.09	0.77	0.52	-0.47	0.64	-0.05	0.39	-0.24	-0.22	0.86
Retained Earnings	-0.63	0.05	-0.74		-0.89	-0.97	-0.57	-0.2	-0.28	-0.2	-0.27	-0.97	-0.83	-0.04	-0.97	-0.33	-0.85	-0.14	-0.16	-0.86
Net Receivables	0.69	0.1	0.62	-0.89		0.87	0.67	0.29	0.57	0.21	0.41	0.86	0.87	0.21	0.92	0.45	0.86	0.28	0.31	0.75
Total Liab	0.49	-0.23	0.84	-0.97	0.87		0.43	0.15	0.33	0.22	0.14	0.96	0.8	-0.14	0.92	0.35	0.77	0.0	0.02	0.88
Total Current Assets	1.0	0.78	0.03	-0.57	0.67	0.43		0.41	0.4	-0.06	0.89	0.54	0.67	0.83	0.71	0.32	0.79	0.85	0.86	0.2
Short Term Debt	0.39	0.32	-0.32	-0.2	0.29	0.15	0.41		0.53	-0.17	0.14	0.07	0.42	0.32	0.25	0.93	0.51	0.14	0.13	-0.08
Accounts Payable	0.36	0.14	0.11	-0.28	0.57	0.33	0.4	0.53		-0.06	0.25	0.2	0.47	0.19	0.34	0.66	0.44	0.16	0.2	0.12
Common Stock	-0.04	-0.22	0.31	-0.2	0.21	0.22	-0.06	-0.17	-0.06		-0.12	0.23	0.25	-0.18	0.15	-0.05	0.11	-0.11	-0.1	0.33
Short Term Investments	0.87	0.86	-0.09	-0.27	0.41	0.14	0.89	0.14	0.25	-0.12		0.26	0.43	0.9	0.43	0.01	0.51	0.96	0.97	-0.04
Property Plant Equipment	0.6	-0.08	0.77	-0.97	0.86	0.96	0.54	0.07	0.2	0.23	0.26		0.8	0.02	0.96	0.22	0.8	0.16	0.17	0.84
Current Deferred Revenue	0.7	0.17	0.52	-0.83	0.87	0.8	0.67	0.42	0.47	0.25	0.43	0.8		0.25	0.86	0.52	0.87	0.35	0.36	0.6
Net Tangible Assets	0.8	0.99	-0.47	-0.04	0.21	-0.14	0.83	0.32	0.19	-0.18	0.9	0.02	0.25		0.23	0.1	0.4	0.93	0.93	-0.29
Capital Surpluse	0.76	0.13	0.64	-0.97	0.92	0.92	0.71	0.25	0.34	0.15	0.43	0.96	0.86	0.23		0.35	0.89	0.32	0.34	0.76
Short Long Term Debt	0.32	0.08	-0.05	-0.33	0.45	0.35	0.32	0.93	0.66	-0.05	0.01	0.22	0.52	0.1	0.35		0.56	-0.03	-0.03	0.15
Long Term Debt Total	0.82	0.32	0.39	-0.85	0.86	0.77	0.79	0.51	0.44	0.11	0.51	0.8	0.87	0.4	0.89	0.56		0.41	0.42	0.61
Net Invested Capital	0.82	0.91	-0.24	-0.14	0.28	0.0	0.85	0.14	0.16	-0.11	0.96	0.16	0.35	0.93	0.32	-0.03	0.41		1.0	-0.2
Net Working Capital	0.83	0.91	-0.22	-0.16	0.31	0.02	0.86	0.13	0.2	-0.1	0.97	0.17	0.36	0.93	0.34	-0.03	0.42	1.0		-0.18
Capital Stock	0.25	-0.4	0.86	-0.86	0.75	0.88	0.2	-0.08	0.12	0.33	-0.04	0.84	0.6	-0.29	0.76	0.15	0.61	-0.2	-0.18

Click cells to compare fundamentals

Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Competition

Predict Heron Therapeuti

In accordance with the recently published financial statements, Heron Therapeuti has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Commodity Channel Now

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum

All Next

Launch Module

Heron Therapeuti ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Heron Therapeuti's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Heron Therapeuti's managers, analysts, and investors.

Environmental

Governance

Social

Heron Fundamentals

	Return On Equity	-24.09
	Return On Asset	-0.0316
	Profit Margin	(0.09) %
	Operating Margin	0.10 %
	Current Valuation	472.65 M
	Shares Outstanding	152.33 M
	Shares Owned By Insiders	0.77 %
	Shares Owned By Institutions	76.80 %
	Number Of Shares Shorted	30.77 M
	Price To Earning	(5.15) X
	Price To Book	12.60 X
	Price To Sales	2.45 X
	Revenue	144.28 M
	Gross Profit	88.95 M
	EBITDA	(5.06 M)
	Net Income	(13.58 M)
	Cash And Equivalents	83.54 M
	Cash Per Share	0.81 X
	Total Debt	177.76 M
	Debt To Equity	6.64 %
	Current Ratio	1.77 X
	Book Value Per Share	(0.22) X
	Cash Flow From Operations	(22.53 M)
	Short Ratio	15.90 X
	Earnings Per Share	(0.09) X
	Price To Earnings To Growth	(0.18) X
	Target Price	6.0
	Number Of Employees	122
	Beta	1.55
	Market Capitalization	353.41 M
	Total Asset	233.15 M
	Retained Earnings	(1.92 B)
	Working Capital	117.56 M
	Current Asset	134.75 M
	Current Liabilities	19.73 M
	Net Asset	233.15 M

About Heron Therapeuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC